Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Guaranteeing Quality Medical care with Federal medical care Benefit Plans. - 2What’s your chronotype? Knowing whether you’re a night owl or an early bird could help you do better on tests and avoid scams
- 3Support Your Investment funds with These Individual accounting Thoughts
- 4Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
- 56 US States for Fly Fishing
- The most effective method to Pick the Right Material Organization: Your Definitive Aide
- Most loved Solace Food: What's Your Definitive Comfortable Feast?
- Geminid shooting stars: One of 2025's most exciting meteor showers begins tonight
- Conquering Language Boundaries: Individual Accounts of Multilingualism
- The Best 20 Tunes that Characterized an Age
- Home Plan Tips for Seniors
- 5 Side interests That Work on Psychological well-being
- RFK Jr. says he's following 'gold standard' science. Here's what to know
- Top Smoothie Flavor: What's Your Mix?
